Biggest News Aggregation in the World
📰 Ciences News

Page 130 - Ciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.

BioHarvest Sciences Inc.: Royal Emerald Pharmaceuticals Partners with BioHarvest Sciences to Supply Disruptive Cannabis Solutions to Companies Conducting FDA-Approved Medical Research

This collaboration ensures first-of-their-kind consistent cannabinoid compositions for 575 DEA-licensed cannabis medical research institutions developing cures for PTSD, pain management, anxiety conditions
United States United Kingdom British Columbia Ilan Sobel Jackie Devereaux Dave Ryan

BioHarvest Sciences Inc. Announces Closing of the Second Tranche of Private Placement of Convertible Notes and Expects the Offering to Be Oversubscribed and to Close an Additional Tranche of up to $3 Million by December 15, 2022

This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2022)
United Kingdom British Columbia Ilan Sobel Dave Ryan Bioharvest Sciences Inc Israel Newsfile Corp

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BioHarvest Sciences Inc.: BioHarvest Sciences CEO to Detail Multi-Pronged Cannabis Strategy in North America at Online Webinar, Nov 16 at 2pm ET

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 14, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that CEO
United States United Kingdom British Columbia Ilan Sobel Dave Ryan Bioharvest Sciences Inc

StageZero Life Sciences Ltd: StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

TORONTO, ON / ACCESSWIRE / November 11, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its third quarter operational and financial results
United States James Howard Tripp Rebecca Greco Stagezero Life Sciences Prostate Health Index Stagezero Life Sciences Ltd

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Near-Term Strategic Focus on Intranasal Foralumab for Diseases of the Central Nervous System (CNS)

-Company to host conference call via webcast at 10 am ET-NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing
Irina Koffler Hana Malik Gabriele Cerrone Mattheww Davis Tiziana Life Sciences Lifesci Advisors

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science